In this context, the overexpression of PRAME may be a mechanism by which tumour cells can escape tumour suppressor RAR signalling [6], e.g., by interacting with RAR in a ligand-dependent manner and inhibiting RAR-dependent transactivation by interacting with PcG complexes. Here, PRAME is linked to neoplasm.